País: Singapur
Idioma: inglés
Fuente: HSA (Health Sciences Authority)
REVVITY SINGAPORE PTE. LTD.
Class C IVD
Wallac Oy
Immunology
This kit is intended for the quantitative in vitro determination of human biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency using the GSP® instrument.
Models: GSP® Neonatal Biotinidase kit - 3307-0010, GSP® Genetic screening processor - 2021-0010
2021-11-16